Skip to main content
Hester Biosciences Ltd logo

Hester Biosciences Ltd — Investor Relations & Filings

Ticker · HESTERBIO ISIN · INE782E01017 LEI · 984500836B9EB1DC4935 BSE.NS Manufacturing
Open in API
Filings indexed 672 across all filing types
Latest filing 2022-08-17 Regulatory Filings
Country IN India
Listing BSE.NS HESTERBIO

About Hester Biosciences Ltd

https://www.hester.in/

Hester Biosciences Ltd specializes in the development, manufacturing, and marketing of animal healthcare products. The company primarily focuses on two segments: poultry healthcare and livestock healthcare. Its extensive product portfolio includes a wide range of live and inactivated vaccines, as well as health products such as therapeutics, herbal supplements, and disinfectants. Hester is recognized for its significant contributions to global animal disease control programs, particularly in the eradication of Peste des Petits Ruminants (PPR) and Brucellosis. The company operates advanced manufacturing facilities and maintains a robust distribution network to serve domestic and international markets. By leveraging research and development, Hester provides diagnostic services and technical support to enhance animal productivity and welfare. Its commitment to quality and innovation has established it as a key provider of biologicals and health solutions for the veterinary sector.

Recent filings

Filing Released Lang Actions
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges regarding the loss of share certificates by shareholders, pursuant to a specific regulation under SEBI (Listing Obligations and Disclosure Requirements). It is a compliance announcement related to share certificates and trading caution, not a financial report, management change, or voting result. The content fits the category of a regulatory announcement that does not fall under other specific categories like share issue or director dealings. Therefore, it is best classified as a Regulatory Filing (RNS). The document length is short and it is an official compliance communication, not a report or announcement of a report publication.
2022-08-17 English
Newspaper Advertisements
Regulatory Filings
2022-08-12 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a notification about the availability of the audio recording of the earnings conference call for the quarter ended 30 June 2022. It references the earnings call and provides a link to the recording, but does not contain the transcript or financial data itself. The document length is short (1036 characters) and serves as an announcement rather than the full transcript. According to the definitions, a full transcript of the earnings call is classified as Call Transcript (CT), but this document is only an announcement of the recording availability. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about the earnings call recording availability, not the transcript itself.
2022-08-10 English
Press Release
Interim / Quarterly Report Classification · 100% confidence The document is dated 10 August 2022 and is addressed to stock exchanges (BSE and NSE) with a subject line indicating the outcome of a Board Meeting. It reports the approval of standalone and consolidated unaudited financial results for the quarter ended 30 June 2022. The document includes detailed financial highlights, profitability analysis, and business updates for Q1 FY23, which is a quarterly period. The presence of actual financial data, including revenues, profit margins, EPS, and segment performance, confirms this is a comprehensive interim financial report. The document also references limited review reports, which are typical for quarterly unaudited results. It is not merely an announcement of a report or a certification letter but contains substantive financial data and analysis. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2022-08-10 English
Outcome of Board Meeting
Regulatory Filings
2022-08-10 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 90% confidence The document is a notification to stock exchanges about an upcoming earnings conference call scheduled for August 10, 2022, following the announcement of unaudited financial results for the quarter ended June 30, 2022. It includes details for joining the call and contact information but does not contain the financial results themselves or substantive financial data. The document is short (2005 characters) and serves as an invitation/intimation rather than the transcript or report of the call. Therefore, it should be classified as a Call Transcript (CT) announcement, but since it is only an intimation of the call and not the transcript, the best fit is the Call Transcript (CT) category as it relates directly to the earnings call event.
2022-08-08 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.